Cargando…

Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study

The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onse...

Descripción completa

Detalles Bibliográficos
Autores principales: Perris, Francesco, Fabrazzo, Michele, De Santis, Valeria, Luciano, Mario, Sampogna, Gaia, Fiorillo, Andrea, Catapano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589899/
https://www.ncbi.nlm.nih.gov/pubmed/31263430
http://dx.doi.org/10.3389/fpsyt.2019.00386
_version_ 1783429449726820352
author Perris, Francesco
Fabrazzo, Michele
De Santis, Valeria
Luciano, Mario
Sampogna, Gaia
Fiorillo, Andrea
Catapano, Francesco
author_facet Perris, Francesco
Fabrazzo, Michele
De Santis, Valeria
Luciano, Mario
Sampogna, Gaia
Fiorillo, Andrea
Catapano, Francesco
author_sort Perris, Francesco
collection PubMed
description The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onset, a higher probability to have more severe obsessive-compulsive symptoms, a higher rate of schizophrenia spectrum disorders in their first-degree relatives, and a poorer insight compared to OCD patients. During the 3-year follow-up period, these patients showed a lower rate of recovery, thus requiring augmentation with different psychotropic medications, including low doses of antipsychotics. Our findings suggest that the comorbidity of OCD and SPD causes a poor treatment response, and a reduced probability to recover using standard pharmacological treatment strategies. Further investigations are needed to identify alternative strategies, including psychoeducation and cognitive behavioral therapy, to manage such frequent comorbidity in clinical practice.
format Online
Article
Text
id pubmed-6589899
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65898992019-07-01 Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study Perris, Francesco Fabrazzo, Michele De Santis, Valeria Luciano, Mario Sampogna, Gaia Fiorillo, Andrea Catapano, Francesco Front Psychiatry Psychiatry The present study aims to analyze the clinical and socio-demographic characteristics of patients with obsessive-compulsive disorder (OCD) in comorbidity with schizotypal personality disorder (SPD), as well as the response rate to pharmacological treatments. OCD+SPD patients had a younger age at onset, a higher probability to have more severe obsessive-compulsive symptoms, a higher rate of schizophrenia spectrum disorders in their first-degree relatives, and a poorer insight compared to OCD patients. During the 3-year follow-up period, these patients showed a lower rate of recovery, thus requiring augmentation with different psychotropic medications, including low doses of antipsychotics. Our findings suggest that the comorbidity of OCD and SPD causes a poor treatment response, and a reduced probability to recover using standard pharmacological treatment strategies. Further investigations are needed to identify alternative strategies, including psychoeducation and cognitive behavioral therapy, to manage such frequent comorbidity in clinical practice. Frontiers Media S.A. 2019-06-17 /pmc/articles/PMC6589899/ /pubmed/31263430 http://dx.doi.org/10.3389/fpsyt.2019.00386 Text en Copyright © 2019 Perris, Fabrazzo, De Santis, Luciano, Sampogna, Fiorillo and Catapano http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Perris, Francesco
Fabrazzo, Michele
De Santis, Valeria
Luciano, Mario
Sampogna, Gaia
Fiorillo, Andrea
Catapano, Francesco
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
title Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
title_full Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
title_fullStr Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
title_full_unstemmed Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
title_short Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
title_sort comorbidity of obsessive-compulsive disorder and schizotypal personality disorder: clinical response and treatment resistance to pharmacotherapy in a 3-year follow-up naturalistic study
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589899/
https://www.ncbi.nlm.nih.gov/pubmed/31263430
http://dx.doi.org/10.3389/fpsyt.2019.00386
work_keys_str_mv AT perrisfrancesco comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy
AT fabrazzomichele comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy
AT desantisvaleria comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy
AT lucianomario comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy
AT sampognagaia comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy
AT fiorilloandrea comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy
AT catapanofrancesco comorbidityofobsessivecompulsivedisorderandschizotypalpersonalitydisorderclinicalresponseandtreatmentresistancetopharmacotherapyina3yearfollowupnaturalisticstudy